We are live on ! Find out more
PODD icon

Insulet

432 hedge funds and large institutions have $16.2B invested in Insulet in 2020 Q3 according to their latest regulatory filings, with 55 funds opening new positions, 172 increasing their positions, 141 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more funds holding in top 10

Funds holding in top 10: 59 (+4)

25% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 44

22% more capital invested

Capital invested by funds: $13.3B → $16.2B (+$2.94B)

22% more repeat investments, than reductions

Existing positions increased: 172 | Existing positions reduced: 141

2% more funds holding

Funds holding: 423432 (+9)

0.65% more ownership

Funds ownership: 103.84%104.49% (+0.65%)

1% less call options, than puts

Call options by funds: $44.1M | Put options by funds: $44.5M

Holders
432
Holders Change
+9
Holders Change %
+2.13%
% of All Funds
8.69%
Holding in Top 10
9
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+80%
% of All Funds
0.18%
New
55
Increased
172
Reduced
141
Closed
44
Calls
$44.1M
Puts
$44.5M
Net Calls
-$395K
Net Calls Change
+$7.34M

PODD Hedge Fund Activity: Q3 2020 in Review

432 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2020, worth a combined $16.2B — up 22% from $13.3B a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new PODD positions and 44 closed out — a net gain of 11 holders — while 172 added to existing stakes and 141 trimmed.

The largest buyer was Lone Pine Capital, opening a new position worth an estimated $97.3M. The largest seller was Carillon Tower Advisers, cutting an estimated $79.3M.

  • 432 institutional investors held Insulet (PODD) as of Q3 2020, up from 423 in Q2 2020.
  • Funds reported $16.2B of Insulet stock for Q3 2020, up 22% quarter-over-quarter.
  • 55 funds opened new Insulet positions in Q3 2020 and 44 closed out, a net change of +11 holders.
  • The largest Insulet buyer in Q3 2020 was Lone Pine Capital, an estimated $97.3M added.
  • The largest Insulet seller in Q3 2020 was Carillon Tower Advisers, an estimated $79.3M sold.

Based on aggregated 13F filings for Q3 2020.